Want to see HK:2522 full AI Analyst Report?
2522 Stock Chart & Stats
HK$8.10
-HK$4.70(-9.29%)
At close: 4:00 PM EST
HK$8.10
-HK$4.70(-9.29%)
Day’s Range― - ―
52-Week RangeHK$3.74 - HK$18.51
Previous CloseN/A
Volume38.00K
Average Volume (3M)516.12K
Market Cap
HK$2.32B
Enterprise ValueHK$1.98K
Total Cash (Recent Filing)HK$585.83M
Total Debt (Recent Filing)HK$703.76M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Mar 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding343,563,570
10 Day Avg. Volume448,850
30 Day Avg. Volume516,120
Financial Highlights & Ratios
PEG Ratio-6.51
Price to Book (P/B)1.33
Price to Sales (P/S)3.03
P/FCF Ratio45.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.06
Revenue Forecast (FY)HK$1.10B
Bulls Say, Bears Say
Bulls Say
Revenue RecoveryThe return to revenue growth indicates that demand and business activity recovered after the prior-year contraction. If this improvement persists, a rebuilding top line can support operating leverage, strengthen investment capacity, and provide a foundation for more stable earnings over the next several quarters.
Improved Operating Cash FlowThe sharp improvement in operating cash flow suggests that cash conversion from the business strengthened alongside the earnings recovery. More internally generated cash can help fund operations and investment, reduce reliance on external financing, and improve financial resilience if the improvement proves sustainable.
Meaningful Equity BaseA substantially larger equity base than debt provides a meaningful balance-sheet cushion and indicates manageable leverage on the reported figures. This financial capacity can support continued operations and investment while giving the company greater ability to absorb volatility than a highly leveraged capital structure.
Bears Say
Rising DebtThe increase in debt raises the company’s fixed financial obligations and reduces some of the flexibility provided by its equity base. If borrowing continues to rise without a comparable improvement in earnings and cash generation, interest burdens and refinancing needs could constrain future capital allocation.
Volatile Free Cash FlowThe large swing in free cash flow shows that cash available after investment can vary materially between periods. Such volatility makes funding capacity less predictable, may require greater reliance on the balance sheet during weak years, and complicates sustained investment or shareholder-return planning.
Thin And Inconsistent ProfitabilityAlthough earnings returned to positive territory, the 2025 profit remained very small relative to the preceding loss and earlier profit. This uneven record indicates that revenue recovery has not yet translated into durable bottom-line performance, leaving returns vulnerable to further operating fluctuations.
Jiangxi Rimag Group Co., Ltd. Class H News
2522 FAQ
What was Jiangxi Rimag Group Co., Ltd. Class H’s price range in the past 12 months?
Jiangxi Rimag Group Co., Ltd. Class H lowest stock price was HK$3.74 and its highest was HK$18.51 in the past 12 months.
What is Jiangxi Rimag Group Co., Ltd. Class H’s market cap?
Jiangxi Rimag Group Co., Ltd. Class H’s market cap is HK$2.32B.
When is Jiangxi Rimag Group Co., Ltd. Class H’s upcoming earnings report date?
Jiangxi Rimag Group Co., Ltd. Class H’s upcoming earnings report date is Mar 26, 2027 which is in 175 days.
How were Jiangxi Rimag Group Co., Ltd. Class H’s earnings last quarter?
Jiangxi Rimag Group Co., Ltd. Class H released its earnings results on Aug 25, 2026. The company reported -HK$0.042 earnings per share for the quarter.
Is Jiangxi Rimag Group Co., Ltd. Class H overvalued?
According to Wall Street analysts Jiangxi Rimag Group Co., Ltd. Class H’s price is currently Overvalued.
Does Jiangxi Rimag Group Co., Ltd. Class H pay dividends?
Jiangxi Rimag Group Co., Ltd. Class H does not currently pay dividends.
What is Jiangxi Rimag Group Co., Ltd. Class H’s EPS estimate?
Jiangxi Rimag Group Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jiangxi Rimag Group Co., Ltd. Class H have?
Jiangxi Rimag Group Co., Ltd. Class H has 343,563,570 shares outstanding.
What happened to Jiangxi Rimag Group Co., Ltd. Class H’s price movement after its last earnings report?
Jiangxi Rimag Group Co., Ltd. Class H reported an EPS of -HK$0.042 in its last earnings report. Following the earnings report the stock price went down -4.043%.
Which hedge fund is a major shareholder of Jiangxi Rimag Group Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2522
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Jiangxi Rimag Group Co., Ltd. Class H Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
29.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Jiangxi Rimag Group Co., Ltd. Class H
Operating across China, Jiangxi Rimag Group Co., Ltd. specializes in providing medical imaging services. The company delivers a comprehensive suite of diagnostic imaging procedures, including MRI, CT, PET scans, X-rays, ultrasounds, and mammography, serving both patients and other healthcare sector clients. It also offers sophisticated imaging solution services. Additionally, Rimag Cloud provides various digital offerings such as cloud-based storage and film modules, a cloud radiology information system (RIS), a cloud Picture Archive and Communication System (PACS), alongside modules for AI integration and operational management within imaging platforms. The firm also oversees and manages a medical imaging platform that hosts a diverse range of imaging-related services. Supporting its activities is a dedicated research and development center, and it further engages in the distribution of medical equipment and related consumables. Established in 2014, the company maintains its primary office in Beijing, China.
Technical Analysis
EuroEyes International Eye Clinic Limited
―
Chaoju Eye Care Holdings Ltd.
―
Yonghe Medical Group Co., Ltd.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―